Company Filing History:
Years Active: 1988
Title: The Innovative Contributions of Brenda Heath
Introduction
Brenda Heath is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of immunoassays, particularly with her innovative patent related to viral lysis. Her work has implications for the detection and analysis of viral infections, showcasing her expertise and dedication to advancing medical technology.
Latest Patents
Brenda Heath holds a patent for a viral lysis immunoassay system and method. This system includes hemolytic particles that carry non-viral, anti-analyte molecules, along with lysable target cells that lack surface molecules capable of binding to endogenous viral surface molecules. The system is designed to facilitate the binding of particles to target cells, initiate cell lysis, and release encapsulated reporter molecules. The analyte to be assayed can either bridge the virus particles to analyte-related molecules on the cell surfaces or compete with target-cell molecules for binding to the particle anti-analyte molecules.
Career Highlights
Brenda is currently employed at Cooper Lipotech Inc., where she continues to develop and refine her innovative technologies. Her work at the company reflects her commitment to advancing the field of immunoassays and improving diagnostic methods.
Collaborations
Brenda collaborates with esteemed colleagues, including Anthony H Huang and Francis J Martin. These partnerships enhance her research and contribute to the development of cutting-edge technologies in her field.
Conclusion
Brenda Heath's contributions to the field of immunoassays through her innovative patent demonstrate her expertise and commitment to advancing medical technology. Her work has the potential to significantly impact the detection and analysis of viral infections, showcasing the importance of innovation in healthcare.